| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMEA/425916/2005 (6.1.06) |
| Publication Date | 06/01/2006 |
| Content Type | News |
|
The European Medicines Agency (EMEA) in January 2006, received the first application for a pandemic influenza vaccine, submitted by GlaxoSmithKline Biologicals. |
|
| Source Link | Link to Main Source http://www.emea.europa.eu/pdfs/general/direct/pr/42591605en.pdf |
| Subject Categories | Health |
| Countries / Regions | Europe |
